Latest Breaking News On - Abiomed europe gmb - Page 1 : comparemela.com

Abiomed Europe GmbH: MEDCERT Enables the Use of the Single Access Procedure with Impella CP Introducer Sheaths in Europe This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210304005331/en/ Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single access procedure with Impella CP introducer sheaths for the treatment of heart disease in Europe. At Abiomed s European headquarters in Aachen, Germany, Impella heart pumps have been developed and produced for more than 20 years to stabilize and recover the human heart. The single access procedure enables the treating physician not only to place Impella heart pumps in the ventricle via the 14 French Impella CP introducer sheaths, but also to insert other catheters and introducer sheaths. Thus, cardiac interventions such as percutaneous coronary interventions can also be performed via the 14 French Impella CP introducer sheaths.

United statesMedizin gmbSebastian heindrichsAbiomed europe gmbEuropean communicationsExchange commissionAbiomed incMedizin gmbhEurope gmbhAachen germanyImpella connectAnnual reportDirector european communicationsஒன்றுபட்டது மாநிலங்களில்ஐரோப்பிய தகவல்தொடர்புகள்பரிமாற்றம் தரகு